MarketBeat reports consensus rating and price target for Eikon Therapeutics, Inc., alongside rating updates from Cantor Fitzgerald and Manufacturers Life Insurance Company.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reports consensus rating and price target for Eikon Therapeutics, Inc., alongside rating updates from Cantor Fitzgerald and Manufacturers Life Insurance Company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
MarketBeat
American personal finance blog
Nothing else this week.
Related events
- Cantor Fitzgerald, Citigroup, and MarketBeat issued rating updates and price targets for Rigel Pharmaceuticals, Inc.
- MarketBeat provided consensus ratings while Cantor Fitzgerald and Jefferies Financial Group issued rating updates for Primoris Services Corporation.
- MarketBeat reported the stock's average rating while Citigroup reiterated a buy rating and Cantor Fitzgerald restated an overweight rating for Beta Technologies.
- Multiple financial firms, including Raymond James, Wells Fargo, UBS, Cantor Fitzgerald, and KeyCorp, issued rating updates and target price changes on November 2, 2026.
- Barclays dropped its target price and set an underweight rating, while Cantor Fitzgerald also issued an underweight rating for Polestar.